Bime, Christian
Casanova, Nancy G.
Camp, Sara M.
Oita, Radu C.
Ndukum, Juliet
Hernon, Vivian Reyes
Oh, Dong Kyu
Li, Yansong
Greer, Phil J.
Whitcomb, David C.
Papachristou, Georgios I.
Garcia, Joe G. N.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL126609, HL126609, HL126609, HL126609, K08 HL141623, HL126609, HL126609)
Article History
Received: 31 January 2022
Accepted: 26 May 2022
First Online: 15 June 2022
Declarations
:
: Institutional review boards at each institution approved the study protocols. The University of Pittsburgh (IRB#STUDY20060223) Asan Medical Center, Seoul, Korea (Approval #2001–0001), US Army (IRB# L-12–004), NHLBI Biolincc specimens from the Fluid and Catheter Treatment Trial (FACTT) study, the University of Arizona (IRB#1312168664R001) and University of Illinois (IRB #20120192).Informed consent was obtained from all the subjects and/or their legal guardian(s). The research was carried out according to the principles of the Declaration of Helsinki.
: Consent for publication not applicable.
: The authors have declared no potential conflicts of interests.